2-[2-[2-oxo-2-[(11S)-10,11,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethyl]sulfanyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-1-yl]acetonitrile

C31H45N3O2S — CID 143830328

IUPAC2-[2-[2-oxo-2-[(11S)-10,11,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethyl]sulfanyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-1-yl]acetonitrile
SMILESCC1CC2(C)C(C(=O)CSC3=NC4CCCCC4N3CC#N)CCC2C2CCC3CC(=O)CCC3(C)C12
InChIInChI=1S/C31H45N3O2S/c1-19-17-31(3)23(22-9-8-20-16-21(35)12-13-30(20,2)28(19)22)10-11-24(31)27(36)18-37-29-33-25-6-4-5-7-26(25)34(29)15-14-32/h19-20,22-26,28H,4-13,15-18H2,1-3H3
InChIKeyGXDLJPKLEXRMRA-UHFFFAOYSA-N
MW523.79 g/mol
LogP6.27
Rot. Bonds4

About 2-[2-[2-oxo-2-[(11S)-10,11,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethyl]sulfanyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-1-yl]acetonitrile

2-[2-[2-oxo-2-[(11S)-10,11,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethyl]sulfanyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-1-yl]acetonitrile (PubChem CID 143830328) has the molecular formula C31H45N3O2S and a molecular weight of 523.79 g/mol. Its IUPAC name is 2-[2-[2-oxo-2-[(11S)-10,11,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethyl]sulfanyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-1-yl]acetonitrile.

Molecular Properties

Compound Name2-[2-[2-oxo-2-[(11S)-10,11,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethyl]sulfanyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-1-yl]acetonitrile
PubChem CID143830328
Molecular FormulaC31H45N3O2S
Molecular Weight523.79 g/mol
Exact Mass523.32
IUPAC Name2-[2-[2-oxo-2-[(11S)-10,11,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethyl]sulfanyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-1-yl]acetonitrile
SMILESCC1CC2(C)C(C(=O)CSC3=NC4CCCCC4N3CC#N)CCC2C2CCC3CC(=O)CCC3(C)C12
InChIInChI=1S/C31H45N3O2S/c1-19-17-31(3)23(22-9-8-20-16-21(35)12-13-30(20,2)28(19)22)10-11-24(31)27(36)18-37-29-33-25-6-4-5-7-26(25)34(29)15-14-32/h19-20,22-26,28H,4-13,15-18H2,1-3H3
InChIKeyGXDLJPKLEXRMRA-UHFFFAOYSA-N
XLogP6.27
TPSA73.53 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds4
Heavy Atoms37
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500523.79
LogP ≤ 56.27
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'cyanamide', 'substructure': 'N/A'}

Analyze 2-[2-[2-oxo-2-[(11S)-10,11,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethyl]sulfanyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-1-yl]acetonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[2-[2-oxo-2-[(11S)-10,11,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethyl]sulfanyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-1-yl]acetonitrile?
The IUPAC name of 2-[2-[2-oxo-2-[(11S)-10,11,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethyl]sulfanyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-1-yl]acetonitrile (CID 143830328) is 2-[2-[2-oxo-2-[(11S)-10,11,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethyl]sulfanyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-1-yl]acetonitrile.
What is the SMILES notation for 2-[2-[2-oxo-2-[(11S)-10,11,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethyl]sulfanyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-1-yl]acetonitrile?
The canonical SMILES for 2-[2-[2-oxo-2-[(11S)-10,11,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethyl]sulfanyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-1-yl]acetonitrile is CC1CC2(C)C(C(=O)CSC3=NC4CCCCC4N3CC#N)CCC2C2CCC3CC(=O)CCC3(C)C12.
What is the InChIKey of 2-[2-[2-oxo-2-[(11S)-10,11,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethyl]sulfanyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-1-yl]acetonitrile?
The InChIKey is GXDLJPKLEXRMRA-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H45N3O2S/c1-19-17-31(3)23(22-9-8-20-16-21(35)12-13-30(20,2)28(19)22)10-11-24(31)27(36)18-37-29-33-25-6-4-5-7-26(25)34(29)15-14-32/h19-20,22-26,28H,4-13,15-18H2,1-3H3.
What are the key properties of 2-[2-[2-oxo-2-[(11S)-10,11,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethyl]sulfanyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-1-yl]acetonitrile?
2-[2-[2-oxo-2-[(11S)-10,11,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethyl]sulfanyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-1-yl]acetonitrile has a molecular weight of 523.79 g/mol, XLogP of 6.27, 4 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-[2-oxo-2-[(11S)-10,11,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethyl]sulfanyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-1-yl]acetonitrile is sourced from PubChem (CID 143830328), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).